Improving the pharmaceutical care for (liver) transplant recipients


Farmacokinetiek en -dynamiek

Part 1: Optimizing ribavirin therapy in transplant recipients with a chronic hepatitis E virus infection by devoloping a NONMEM model for ribavirin. Part 2: Improving immunosuppressive therapy in liver transplant recipients by performing 2 RCT's in which different immunosuppresive strategies will be compared to modify the tacrolimus related toxicity in this population. Part 3: Evaluate the contribution of an outpatient medication service for liver transplant recipients.


2020

2024

Erasmus MC

Midas B. Mulder

Prof. Dr. Herold Metselaar

Dr. B.C.M. de Winter
Dr. S. Darwish Murad